Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RF Capital Group is a leading Canadian wealth management firm that operates primarily through its flagship subsidiary, Richardson Wealth. While fundamentally a financial services provider, the company maintains a significant strategic focus on the healthcare and life sciences sectors through a long-term alliance with Bloom Burton & Co., a premier healthcare investment bank. This partnership allows RF Capital to offer specialized investment research, capital markets access, and customized wealth solutions specifically for biotechnology, pharmaceutical, and medical technology companies and their investors. Headquartered in Toronto, the firm manages over $43 billion in assets under administration and serves a large base of healthcare professional clients. In October 2025, RF Capital Group was acquired by iA Financial Corporation for approximately $597 million to bolster its high-net-worth distribution platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RF Capital Group.